Skip navigation

Explore the Impact of Accumulator Programs, Copay Blocks and Point of Sale Rebates on Patient Affordability

October 2-3, 2018
  • Philadelphia, PA

Now in its 6th year, CBI’s Coupon and Copay brings together top industry leaders in copay program development from key stakeholder groups to address the recent rise in accumulator programs, copay blocks and point of sale rebates and their impact on patient adherence and affordability.

Join the Dialogue and Discuss:

  • Cost shifting trends in drug plan benefit design —
    Gain clarity on the impact of the increase in copay accumulator programs and high deductible plans
  • The current landscape of the prescription drug supply chain — Assess the potential impact of industry consolidations, state copay block legislation and possible disruptions in the prescription drug distribution channel
  • Evolving PBM rebate policies and practices — How and where will point of sale rebates benefit the consumer?
  • The patient perspective in navigating the healthcare landscape to gain access to the right prescription drug medication — Understand what is actually involved in a patient’s journey
  • Operational design and execution of copay programs —
    Ensure that program design, availability and effectiveness meets target patient population
  • The merits of value-based contracts between payers and manufacturers — Determine the impact on patient outcomes
  • Potential collaboration models amongst key stakeholders to keep a focus on patient access and affordability as well as manage costs and meet stakeholder expectations
  • Effective strategies to increase copay program awareness and utilization

Previous Attendee Acclaim:

Excellent variety of perspectives from speakers.

Sr. Product Manager, Prime Therapeutics

6th Annual Coupon and Copay

Explore the Impact of Accumulator Programs, Copay Blocks and Point of Sale Rebates on Patient Affordability

Now in its 6th year, CBI’s Coupon and Copay brings together top industry leaders in copay program development from key stakeholder groups to address the recent rise in accumulator programs, copay blocks and point of sale rebates and their impact on patient adherence and affordability.

Join the Dialogue and Discuss:

  • Cost shifting trends in drug plan benefit design —
    Gain clarity on the impact of the increase in copay accumulator programs and high deductible plans
  • The current landscape of the prescription drug supply chain — Assess the potential impact of industry consolidations, state copay block legislation and possible disruptions in the prescription drug distribution channel
  • Evolving PBM rebate policies and practices — How and where will point of sale rebates benefit the consumer?
  • The patient perspective in navigating the healthcare landscape to gain access to the right prescription drug medication — Understand what is actually involved in a patient’s journey
  • Operational design and execution of copay programs —
    Ensure that program design, availability and effectiveness meets target patient population
  • The merits of value-based contracts between payers and manufacturers — Determine the impact on patient outcomes
  • Potential collaboration models amongst key stakeholders to keep a focus on patient access and affordability as well as manage costs and meet stakeholder expectations
  • Effective strategies to increase copay program awareness and utilization

Previous Attendee Acclaim:

Excellent variety of perspectives from speakers.

Sr. Product Manager, Prime Therapeutics